Govt may impose anti-dumping duty on Pharma API from China

The recommended duty is USD 12.91 per kg. The finance ministry takes the final decision on imposing duty.

274
Govt of India
Govt of India

Last Updated on January 13, 2024 by The Health Master

The commerce ministry has recommended the imposition of an anti-dumping duty on a active pharmaceutical ingredients (API) from China to guard domestic players from cheap imports.

The Directorate General of Trade Remedies (DGTR) has recommended the duty after concluding in its probe that the API (active pharma ingredient) from China has been exported at dumped prices into India, which has impacted the domestic industry.

“The authority recommends the imposition of the anti-dumping duty on the imports of subject goods,” the directorate said in a notification.

Ceftriaxone Sodium Sterile is an API used in formulations for treating diseases like lower respiratory tract infections, skin and skin structure infections, and surgical prophylaxis.

DGTR had conducted the probe following a complaint from Nectar Life Sciences and Sterile India about the dumping of the chemical.

The recommended duty is USD 12.91 per kg. The finance ministry takes the final decision on imposing duty.

In a separate notification, DGTR has said it has started a sunset review probe to review the need for continued imposition of anti-dumping duties on aluminium foil from China.

The imposition of anti-dumping duty is permissible under the World Trade Organisation (WTO) regime.

The duty is aimed at ensuring fair trading practices and creating a level-playing field for domestic producers vis-a-vis foreign producers and exporters.

Govt is considering revising the DPCO to encourage drug innovation

6 arrested for Codeine cough syrup smuggling to Bangladesh

Andhra Pradesh: Doctor gets patent for Plasma Therapy Kit

Retired Pharmacists to motivate serving Pharmacists

No need to panic over new Covid-19 variant: ICMR

PLI scheme to benefit 55 Pharma Firms: Govt

Nitrite Poppers: Ingesting or inhaling can cause severe injury: USFDA

Pharma industry seeks single window clearance system at CDSCO

2 lakh Pharmacies in India by next year: Biddano

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news